News
US health spending growth slowed in 2012
- Author:
- HT Staff
Credit: Petr Kratochvil In 2012, overall US health expenditures grew slower than the economy as a whole, according to a report by the Centers for...
News
NICE recommends pixantrone for NHL
- Author:
- HT Staff
Credit: Bill Branson Counter to its previous recommendations, the UK’s National Institute for Health and Care Excellence (NICE) is now supporting...
News
Brentuximab vedotin proves active in DLBCL
- Author:
- HT Staff
NEW ORLEANS—Brentuximab vedotin has demonstrated “compelling” antitumor activity in patients with relapsed or refractory diffuse large B-cell...
News
Ponatinib may be returning to market with new safety measures
- Author:
- HT Staff
The US Food and Drug Administration (FDA) is requiring that a number of safety measures be adopted, including changes to ponatinib’s label to...
News
Nilotinib beats imatinib in newly diagnosed CML
- Author:
- HT Staff
NEW ORLEANS—New data indicate a trend for longer overall survival and event-free survival in newly diagnosed chronic myeloid leukemia (CML)...
News
Enzastaurin no better than placebo in DLBCL
- Author:
- HT Staff
NEW ORLEANS—In a phase 3 study, patients with diffuse large B-cell lymphoma (DLBCL) who received post-induction therapy with enzastaurin saw no...
News
Receptor may play key role in sepsis
- Author:
- HT Staff
Researchers have identified a receptor that may be instrumental in the body’s response to sepsis. And they believe this discovery could be the key...
News
Team creates faster method for diagnosing sepsis
- Author:
- HT Staff
A new technique could cut hours off the time it takes to diagnose blood infections, according to a report published in mBio.
News
CDC finds cluster of newborns with late VKDB
- Author:
- HT Staff
The Centers for Disease Control and Prevention (CDC) has identified a small group of newborns in Tennessee with late vitamin K deficiency...
News
FDA approves ibrutinib for previously treated MCL
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has has granted accelerated approval for ibrutinib (Imbruvica) to treat patients with mantle cell...
News
Factor can prevent bleeding in hemophilia A
- Author:
- HT Staff
Researchers found that prophylaxis with rFVIIIFc resulted in low annualized bleeding rates, and patients did not develop neutralizing antibodies...
News
Ponatinib sales and marketing suspended
- Author:
- HT Staff
The agency placed current ponatinib trials on partial clinical hold and asked the drug’s makers, Ariad Pharmaceuticals, to end the phase 3 EPIC...
News
Phase 3 ponatinib trial stopped due to adverse events
- Author:
- HT Staff
All trials of ponatinib were placed on partial clinical hold on October 9, after follow-up data from the phase 2 PACE trial revealed an increased...
News
NICE again rejects pixantrone for NHL
- Author:
- HT Staff
The UK’s National Institute for Health and Care Excellence (NICE) has re-examined its draft guidance for pixantrone (Pixuvri) but come to the same...
News
Ponatinib trials put on partial hold
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has paused new enrollment in the trials. Patients already enrolled will continue to receive ponatinib,...